Suicide is a tragic epidemic among US military veterans, but a new documentary charts how psychedelic drugs offer a glimmer ...
A year after the US Food and Drug Administration (FDA) opened the door to clinical use of lysergic acid diethylamide (LSD), US-based MindMed has launched phase 3 trials in the United States and Europe ...
‘People have been looking for this fungus for years, and one day, I look in the right place, and there it is.’ By Laura Baisas Published Jun 3, 2025 10:38 AM EDT Get the Popular Science daily ...
A team of researchers at the University of California, Davis, made small tweaks to the molecular structure of lysergic acid diethylamide (LSD) to see if it could be turned into an effective ...
Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938, ...
Hosted on MSN
A single dose of LSD seems to reduce anxiety
A single dose of the psychedelic drug LSD seems to reduce anxiety without lasting side effects. “Ours is the first modern trial to look specifically at LSD, or any psychedelic, for generalised anxiety ...
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...
A single dose of an investigational lysergic acid diethylamide (LSD)-based medication known as MM120 (lysergide D-tartrate, Mind Medicine Inc [MindMed]) was associated with a rapid and significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback